Literature DB >> 19388163

Factor H and neisserial pathogenesis.

Jo Anne Welsch1, Sanjay Ram.   

Abstract

Both Neisseria gonorrhoeae and N. meningitidis bind to factor H which enhances their ability to evade complement-dependent killing. While porin is the ligand for human fH on gonococci, meningococci use a lipoprotein called factor H binding protein (fHbp) to bind to factor H and enhance their ability to evade complement-dependent killing. This protein is currently being intensively investigated as a meningococcal vaccine candidate antigen. Consistent with the observation that meningococci cause natural infection only in humans, the organism resists human complement, and are more readily killed by complement from lower animals. This human species-specific complement evasion has important implications for evaluation of vaccine-elicited antibodies using non-human complement sources and development of animal models of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19388163      PMCID: PMC2768413          DOI: 10.1016/j.vaccine.2008.11.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  58 in total

Review 1.  Mechanisms of neisserial serum resistance.

Authors:  U Vogel; M Frosch
Journal:  Mol Microbiol       Date:  1999-06       Impact factor: 3.501

Review 2.  Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.

Authors:  R Würzner
Journal:  Mol Immunol       Date:  1999 Mar-Apr       Impact factor: 4.407

3.  Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.

Authors:  U Vogel; A Weinberger; R Frank; A Müller; J Köhl; J P Atkinson; M Frosch
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat.

Authors:  U Vogel; S Hammerschmidt; M Frosch
Journal:  Med Microbiol Immunol       Date:  1996-09       Impact factor: 3.402

5.  Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.

Authors:  C A Fijen; E J Kuijper; M T te Bulte; M R Daha; J Dankert
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

6.  Identification of complement regulatory domains in human factor H.

Authors:  D L Gordon; R M Kaufman; T K Blackmore; J Kwong; D M Lublin
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

7.  Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model.

Authors:  F G Mackinnon; R Borrow; A R Gorringe; A J Fox; D M Jones; A Robinson
Journal:  Microb Pathog       Date:  1993-11       Impact factor: 3.738

8.  Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria.

Authors:  C A Fijen; E J Kuijper; H G Tjia; M R Daha; J Dankert
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

9.  A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.

Authors:  S Ram; A K Sharma; S D Simpson; S Gulati; D P McQuillen; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae.

Authors:  S Ram; D P McQuillen; S Gulati; C Elkins; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more
  25 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.

Authors:  C J Gill; S Ram; J A Welsch; L Detora; A Anemona
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

3.  O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

Authors:  Shannon Weiman; Satoshi Uchiyama; Feng-Ying C Lin; Donald Chaffin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

4.  Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086).

Authors:  Laura Cendron; Daniele Veggi; Enrico Girardi; Giuseppe Zanotti
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-04-20

5.  Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.

Authors:  Rolando Pajon; Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

6.  fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.

Authors:  Serena Giuntini; David M Vu; Dan M Granoff
Journal:  Vaccine       Date:  2013-06-17       Impact factor: 3.641

7.  Both MisR (CpxR) and MisS (CpxA) Are Required for Neisseria gonorrhoeae Infection in a Murine Model of Lower Genital Tract Infection.

Authors:  Dharanesh Gangaiah; Erica L Raterman; Hong Wu; Kate R Fortney; Hongyu Gao; Yunlong Liu; Ann E Jerse; Stanley M Spinola
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

8.  Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.

Authors:  Srinjoy Chakraborti; Sunita Gulati; Bo Zheng; Frank J Beurskens; Janine Schuurman; Peter A Rice; Sanjay Ram
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

9.  Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

Authors:  Dan M Granoff; Serena Giuntini; Flor A Gowans; Eduardo Lujan; Kelsey Sharkey; Peter T Beernink
Journal:  JCI Insight       Date:  2016-09-08

10.  Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria.

Authors:  Yogesh Hooda; Christine Chieh-Lin Lai; Andrew Judd; Carolyn M Buckwalter; Hyejin Esther Shin; Scott D Gray-Owen; Trevor F Moraes
Journal:  Nat Microbiol       Date:  2016-02-29       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.